Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | |||||
| Cash flow from continuing operating activities | |||||
| Net income from continuing operations | 245.26%3.84M | 122.08%1.11M | -141.26%-5.03M | 156.96%12.2M | --4.75M |
| Other non cashItems | 7.96%19.51K | -6.09%18.07K | -23.72%19.24K | -11.08%25.22K | --28.36K |
| Change in working capital | 37.28%57.42K | -53.34%41.83K | 165.88%89.65K | -7,125.35%-136.08K | --1.94K |
| -Change in other current liabilities | 37.28%57.42K | -53.34%41.83K | 165.88%89.65K | -7,125.35%-136.08K | --1.94K |
| Cash from discontinued operating activities | |||||
| Operating cash flow | -76.58%1.22M | 0.43%5.22M | 162.35%5.19M | 106.74%1.98M | ---29.4M |
| Investing cash flow | |||||
| Cash flow from continuing investing activities | |||||
| Cash from discontinued investing activities | |||||
| Financing cash flow | |||||
| Cash flow from continuing financing activities | |||||
| Net commonstock issuance | --0 | 79.39%-505.72K | 43.27%-2.45M | -127.17%-4.33M | --15.92M |
| Net preferred stock issuance | ---- | ---- | ---- | ---- | --18.05M |
| Cash dividends paid | 48.47%-1.93M | -17.61%-3.74M | -120.43%-3.18M | -167.69%-1.44M | ---539.62K |
| Net other financing activities | --0 | --0 | --0 | --0 | --0 |
| Cash from discontinued financing activities | |||||
| Financing cash flow | 54.60%-1.93M | 24.60%-4.25M | 2.29%-5.64M | -117.26%-5.77M | --33.43M |
| Net cash flow | |||||
| Beginning cash position | 481.11%765.52K | -183.00%-200.87K | -94.00%242.02K | --4.03M | --0 |
| Current changes in cash | -173.23%-707.66K | 318.20%966.39K | 88.31%-442.88K | -194.00%-3.79M | --4.03M |
| End cash position | -92.44%57.86K | 481.11%765.52K | -183.00%-200.87K | -94.00%242.02K | --4.03M |
| Free cash from | -76.58%1.22M | 0.43%5.22M | 162.35%5.19M | 106.74%1.98M | ---29.4M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.